- Home
- ATAI vs SATL Comparison
ATAI vs SATL Comparison
Compare ATAI & SATL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ATAI
- SATL
- Stock Information
- Founded
- ATAI 2018
- SATL 2010
- Country
- ATAI Germany
- SATL United States
- Employees
- ATAI N/A
- SATL N/A
- Industry
- ATAI Biotechnology: Pharmaceutical Preparations
- SATL Radio And Television Broadcasting And Communications Equipment
- Sector
- ATAI Health Care
- SATL Technology
- Exchange
- ATAI Nasdaq
- SATL Nasdaq
- Market Cap
- ATAI 444.7M
- SATL 373.7M
- IPO Year
- ATAI 2021
- SATL N/A
- Fundamental
- Price
- ATAI $4.72
- SATL $3.55
- Analyst Decision
- ATAI Strong Buy
- SATL
- Analyst Count
- ATAI 3
- SATL 0
- Target Price
- ATAI $13.33
- SATL N/A
- AVG Volume (30 Days)
- ATAI 4.8M
- SATL 1.7M
- Earning Date
- ATAI 11-12-2025
- SATL 11-12-2025
- Dividend Yield
- ATAI N/A
- SATL N/A
- EPS Growth
- ATAI N/A
- SATL N/A
- EPS
- ATAI N/A
- SATL N/A
- Revenue
- ATAI $2,309,000.00
- SATL $13,868,000.00
- Revenue This Year
- ATAI $712.99
- SATL N/A
- Revenue Next Year
- ATAI N/A
- SATL N/A
- P/E Ratio
- ATAI N/A
- SATL N/A
- Revenue Growth
- ATAI 510.85
- SATL 1.09
- 52 Week Low
- ATAI $1.03
- SATL $0.93
- 52 Week High
- ATAI $5.34
- SATL $5.49
- Technical
- Relative Strength Index (RSI)
- ATAI 61.12
- SATL 48.05
- Support Level
- ATAI $4.50
- SATL $3.48
- Resistance Level
- ATAI $4.75
- SATL $4.12
- Average True Range (ATR)
- ATAI 0.28
- SATL 0.24
- MACD
- ATAI -0.04
- SATL -0.01
- Stochastic Oscillator
- ATAI 59.28
- SATL 25.97
About ATAI ATAI Life Sciences N.V.
ATAI Life Sciences NV is a clinical-stage biopharmaceutical company on a mission to develop effective mental health treatments to transform patient outcomes. The company's pipeline of psychedelic-based therapies includes VLS-01 (buccal film DMT) for treatment-resistant depression (TRD) and EMP-01 (oral R-MDMA) for social anxiety disorder. It is also advancing a drug discovery program to identify novel, non-hallucinogenic 5-HT2AR agonists for TRD.
About SATL Satellogic Inc.
Satellogic Inc is a provider of satellite imagery to governments and commercial customers globally. It geographically operates in North America, Europe, Asia and South America. It derives maximum revenue from Asia Pacific.